Taysha Gene Therapies, Inc. TSHA
TSHA
Taysha Gene Therapies, Inc. PASG
Passage Bio, Inc. CABA
Cabaletta Bio, Inc. GRTX
Galera Therapeutics, Inc. FDMT
4D Molecular Therapeutics, Inc. FHTX
Foghorn Therapeutics Inc. CCCC
C4 Therapeutics, Inc. STTK
Shattuck Labs, Inc. PRLD
Prelude Therapeutics Incorporated SPRB
Spruce Biosciences, Inc.
Taysha Gene Therapies, Inc. PASG
Passage Bio, Inc. CABA
Cabaletta Bio, Inc. GRTX
Galera Therapeutics, Inc. FDMT
4D Molecular Therapeutics, Inc. FHTX
Foghorn Therapeutics Inc. CCCC
C4 Therapeutics, Inc. STTK
Shattuck Labs, Inc. PRLD
Prelude Therapeutics Incorporated SPRB
Spruce Biosciences, Inc.
Performance
| Periode | TSHA | PASG | CABA | GRTX | FDMT | FHTX | CCCC | STTK | PRLD | SPRB |
|---|---|---|---|---|---|---|---|---|---|---|
| 6M | 290.40 % | 16.84 % | 88.62 % | -27.08 % | 238.40 % | 17.68 % | 81.45 % | 93.70 % | 77.92 % | 61 071.99 % |
| YTD | 163.78 % | -48.97 % | -0.43 % | -56.36 % | 52.66 % | -11.55 % | -38.52 % | 52.07 % | 0.80 % | 42 347.06 % |
| 1Y | 145.23 % | -29.53 % | -45.41 % | -74.26 % | -1.44 % | -45.36 % | -61.73 % | 17.95 % | -35.05 % | 38 372.62 % |
| 3Y | 190.48 % | -66.65 % | 205.26 % | -98.92 % | 21.92 % | -47.75 % | -70.85 % | -39.67 % | -81.05 % | 14 995.65 % |
| 5Y | -77.09 % | -97.34 % | -79.43 % | -99.85 % | -78.02 % | -77.59 % | -90.29 % | -90.32 % | -97.15 % | 932.10 % |
| 10Y | -79.72 % | -98.09 % | -76.80 % | -99.85 % | -78.02 % | -77.59 % | -91.17 % | -90.49 % | -95.19 % | 947.04 % |
| From the beginning | -79.72 % | -98.09 % | -76.80 % | -99.85 % | -78.02 % | -77.59 % | -91.17 % | -90.49 % | -95.19 % | 947.04 % |